In a milestone move that promises to transform healthcare accessibility in the Philippines, PHILUSA Corporation partnered with Bayer Philippines to bring forth a new era of world-class quality medicines at affordable prices through **RHEA Generics**.
The ceremonial signing event was held at the Bayer Philippines Head Office on February 5, 2024, led by president and general manager of PHILUSA Corporation **Neogin Evangelista**, managing director and country division head of Bayer Philippines **Angel Michaelo Evangelista**, and vice president for merchandising of Mercury Drug Corporation **Corazon Lim**.
This partnership marks the 12th collaboration for RHEA Generics, with Bayer Philippines joining the roster of PHILUSA Corporation's global pharmaceutical partners. Together, these industry giants aim to provide Filipino patients with an effective product for the prevention of stroke and treatment of thromboembolic events.
"We're here to help Filipino patients access affordable generic medicines while ensuring their quality, safety, and efficacy," said Evangelista.
Launched in 2014, RHEA Generics is a uni-brand of innovative generic medicines developed in partnership with global pharmaceutical industry leaders, namely: Pfizer, Viatris, Sanofi, GSK, Otsuka, Merck, Fresenius Kabi, OEP Philippines, Lundbeck, Boehringer Ingelheim, and AstraZeneca. Its portfolio of medicines includes treatments for hypertension, diabetes, hypercholesterolemia, respiratory infections, and chronic kidney disease, among others.
RHEA Generics, a homegrown brand of PHILUSA Corporation, is a pioneer in the generics industry with more than 40 years of experience in producing world-class quality and affordable healthcare products. Its availability at Mercury Drug Store branches nationwide further ensures its reliability and accessibility.
For more information and updates, follow the social media pages **RHEA Generics PH** on Facebook and **rheagenericsph** on Instagram.
Comentários